NCT00954642View on ClinicalTrials.gov

A Study of MNRP1685A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Solid Cancers

Interventions

DRUG

bevacizumab

Intravenous repeating dose

DRUG

MNRP1685A

Escalating intravenous dose

DRUG

paclitaxel

Intravenous repeating dose

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY